Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of toll-like receptor 4 by bacterial fimbria-dependent invasion

Infection and Immunity

Volumn 73, Issue 12, 2005, Pages 8050-8059

  Yumoto, Hiromichi ^a,c   Chou, Hsin Hua ^e   Takahashi, Yusuke ^a,d   Davey, Michael ^b   Gibson III, Frank C ^a   Genco, Caroline A ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d KANAGAWA DENTAL COLLEGE   (Japan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BACTERIUM LIPOPOLYSACCHARIDE; CYTOCHALASIN D; DIMETHYL SULFOXIDE; LIGAND; LIPOTEICHOIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYMYXIN; RECEPTOR ANTIBODY; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 4 ANTIBODY; UNCLASSIFIED DRUG;

ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; BACTERIAL COLONIZATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RISK FACTOR; SENSITIZATION; WILD TYPE;

ANTIGENS, BACTERIAL; AORTA; CHEMOKINE CCL2; CYTOCHALASIN D; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FIMBRIAE, BACTERIAL; HUMANS; LIGANDS; LIPOPOLYSACCHARIDES; PORPHYROMONAS GINGIVALIS; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 28444494727     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.12.8050-8059.2005     Document Type: Article

References (46)

1. Arbes, S. J., Jr., G. D. Slade, and J. D. Beck. 1999. Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J. Dent. Res. 78:1777-1782.
2. Beck, J., R. Garcia, G. Heiss, P. S. Vokonas, and S. Offenbacher. 1996. Periodontal disease and cardiovascular disease. J. Periodontol. 67:1123-1137.
3. Berliner, J. A., M. Navab, A. M. Fogelman, J. S. Frank, L. L. Demer, P. A. Edwards, A. D. Watson, and A. J. Lusis. 1995. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91:2488-2496.
4. Binder, C. J., M. K. Chang, P. X. Shaw, Y. I. Miller, K. Hartvigsen, A. Dewan, and J. L. Witztum. 2002. Innate and acquired immunity in atherogenesis. Nat. Med. 8:1218-1226.
5. Bjorkbacka, H., V. V. Kunjathoor, K. J. Moore, S. Koehn, C. M. Ordija, M. A. Lee, T. Means, K. Halmen, A. D. Luster, D. T. Golenbock, and M. W. Freeman. 2004. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10:416-421.
6. Cario, E., and D. K. Podolsky. 2000. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68:7010-7017.
7. +/- mice. J. Dent. Res. 79:313.
8. Deshpande, R. G., M. B. Khan, and C. A. Genco. 1998. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect. Immun. 66:5337-5343.
9. Dorn, B. R., W. A. Dunn, Jr., and A. Progulske-Fox. 1999. Invasion of human coronary artery cells by periodontal pathogens. Infect. Immun. 67:5792-5798.
10. Dorn, B. R., W. A. Dunn, Jr., and A. Progulske-Fox. 2001. Porphyromonas gingivalis traffics to autophagosomes in human coronary artery endothelial cells. Infect. Immun. 69:5698-5708.
11. Duncan, R. L., Jr., J. Hodman, V. L. Tesh, and D. C. Morrison. 1986. Immunologic activity of lipopolysaccharides released from macrophages after the uptake of intact E. coli in vitro. J. Immunol. 136:2924-2929.
12. Edfeldt, K., J. Swedenborg, G. K. Hansson, and Z. Q. Yan. 2002. Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105:1158-1161.
13. Faure, E., L. Thomas, H. Xu, A. Medvedev, O. Equils, and M. Arditi. 2001. Bacterial lipopolysaccharide and IFN-γ induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation. J. Immunol. 166:2018-2024.
14. Frantz, S., L. Kobzik, Y. D. Kim, R. Fukazawa, R. Medzhitov, R. T. Lee, and R. A. Kelly. 1999. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Investig. 104:271-280.
15. Gibson, F. C., III, C. Hong, H.-H. Chou, H. Yumoto, J. Chen, E. Lien, J. Wong, and C. A. Genco. 2004. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109:2801-2806.
16. Glurich, I., S. Grossi, B. Albini, A. Ho, R. Shah, M. Zeid, H. Baumann, R. J. Genco, and E. De Nardin. 2002. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin. Diagn. Lab. Immunol. 9:425-432.
17. Hajishengallis, G., M. Martin, R. E. Schifferle, and R. J. Genco. 2002. Counteracting interactions between lipopolysaccharide molecules with differential activation of Toll-like receptors. Infect. Immun. 70:6658-6664.
18. Hajishengallis, G., M. Martin, H. T. Sojar, A. Sharma, R. E. Schifferle, E. DeNardin, M. W. Russell, and R. J. Genco. 2002. Dependence of bacterial protein adhesins on Toll-like receptors for proinflammatory cytokine induction. Clin. Diagn. Lab. Immunol. 9:403-411.
19. Haraszthy, V. I., J. J. Zambon, M. Trevisan, M. Zeid, and R. J. Genco. 2000. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol. 71:1554-1560.
20. Hausmann, M., S. Kiessling, S. Mestermann, G. Webb, T. Spottl, T. Andus, J. Scholmerich, H. Herfarth, K. Ray, W. Falk, and G. Regler. 2002. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122:1987-2000.
21. Hoffmann, J. A., F. C. Kafatos, C. A. Janeway, and R. A. Ezekowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284:1313-1318.
22. Imler, J. L., and J. A. Hoffmann. 2003. Toll signaling: the TIReless quest for specificity. Nat. Immunol. 4:105-106.
23. Janeway, C. A., Jr., and R. Medzhitov. 1999. Lipoproteins take their toll on the host. Curr. Biol. 9:R879-R882.
24. Kawai, T., O. Takeuchi, T. Fujita, J. Inoue, P. F. Muhlradt, S. Sato, K. Hoshino, and S. Akira. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167:5887-5894.
25. Kiechl, S., E. Lorenz, M. Reindl, C. J. Wiedermann, F. Oberhollenzer, E. Bonora, J. Willeit, and D. A. Schwartz. 2002. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347:185-192.
26. Kolltveit, K. M., and H. M. Eriksen. 2001. Is the observed association between periodontitis and atherosclerosis causal? Eur. J. Oral. Sci. 109:2-7.
27. Li, L., E. Messas, E. L. Batista, Jr., R. A. Levine, and S. Amar. 2002. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105:861-867.
28. Lin, Y., H. Lee, A. H. Berg, M. P. Lisanti, L. Shapiro, and P. E. Scherer. 2000. The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J. Biol. Chem. 275:24255-24263.
29. Loesche, W. J., A. Schork, M. S. Terpenning, Y. M. Chen, B. L. Dominguez, and N. Grossman. 1998. Assessing the relationship between dental disease and coronary heart disease in elderly U.S. veterans. J. Am. Dent. Assoc. 129:301-311.
30. Loos, B. G., J. Craandijk, F. J. Hoek, P. M. Wertheim-van Dillen, and U. van der Velden. 2000. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J. Periodontol. 71:1528-1534.
31. Malek, R., J. G. Fisher, A. Caleca, M. Stinson, C. J. van Oss, J. Y. Lee, M. I. Cho, R. J. Genco, R. T. Evans, and D. W. Dyer. 1994. Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J. Bacteriol. 176:1052-1059.
32. Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:295-298.
33. Michelsen, K. S., M. H. Wong, P. K. Shah, W. Zhang, J. Yano, T. M. Doherty, S. Akira, T. B. Rajavashisth, and M. Arditi. 2004. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA 101:10679-10684.
34. Monick, M. M., T. O. Yarovinsky, L. S. Powers, N. S. Butler, A. B. Carter, G. Gudmundsson, and G. W. Hunninghake. 2003. Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J. Biol. Chem. 278:53035-53044.
35. Muzio, M., D. Bosisio, N. Polentarutti, G. D'Amico, A. Stoppacciaro, R. Mancinelli, C. van't Veer, G. Penton-Rol, L. P. Ruco, P. Allavena, and A. Mantovani. 2000. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164:5998-6004.
36. Njoroge, T., R. J. Genco, H. T. Sojar, N. Hamada, and C. A. Genco. 1997. A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect. Immun. 65:1980-1984.
37. Nomura, F., S. Akashi, Y. Sakao, S. Sato, T. Kawai, M. Matsumoto, K. Nakanishi, M. Kimoto, K. Miyake, K. Takeda, and S. Akira. 2000. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J. Immunol. 164:3476-3479.
38. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
39. Ross, R. 1999. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340:115-126.
40. Shuto, T., A. Imasato, H. Jono, A. Sakai, H. Xu, T. Watanabe, D. D. Rixter, H. Kai, A. Andalibi, F. Linthicum, Y. L. Guan, J. Han, A. C. Cato, D. J. Lim, S. Akira, and J. D. Li. 2002. Glucocorticoids synergistically enhance non-typeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J. Biol. Chem. 277:17263-17270.
41. Sojar, H. T., J. Y. Lee, G. S. Bedi, M. I. Cho, and R. J. Genco. 1991. Purification, characterization and immunolocalization of fimbrial protein from Porphyromonas (Bacteroides) gingivalis. Biochem. Biophys. Res. Commun. 175:713-719.
42. Vapaatalo, H., and E. Mervaala. 2001. Clinically important factors influencing endothelial function. Med. Sci. Monit. 7:1075-1085.
43. Wang, T., W. P. Lafuse, and B. S. Zwilling. 2000. Regulation of Toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J. Immunol. 165:6308-6313.
44. Wesphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides; extraction with phenol water and further applications of the procedure. Methods Carbohydr. Chem. 5:83-91.
45. Xu, X. H., P. K. Shah, E. Faure, O. Equils, L. Thomas, M. C. Fishbein, D. Luthringer, X. P. Xu, T. B. Rajavashisth, J. Yano, S. Kaul, and M. Arditi. 2001. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104:3103-3108.
46. Zeuke, S., A. J. Ulmer, S. Kusumoto, H. A. Katus, and H. Heine. 2002. TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. Cardiovasc. Res. 56:126-134.